Related Experiment Video
Updated: Aug 24, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma
José Antonio López-Guerrero1, Concha López-Ginés, Antonio Pellín
1Department of Pathology, School of Medicine, University of Valencia, Spain.
Abstract:
Osteosarcoma (OS) displays complex karyotypes with numerical changes as well as structural abnormalities suggesting that several oncogenes and tumor suppressor genes may be implicated in the biology of OS. The aim of our study was to investigate the possible implication of the molecular alterations of the G1 to S-phase checkpoint genes in the pathogenesis of OS. We analyzed samples from 29 patients and found molecular alterations of the RB and TP53 genes in 6 (21%) and 3 (10%) cases, respectively. Homozygous deletion of the INK4A/ARF locus and methylation of INK4A was detected in 3 (10%) and 2 (7%) cases, respectively. CDK4 and MDM2 co-amplification was observed in 1 case (3%). Cyclin D3 is differentially expressed in a greater proportion than D1- and D2-type cyclins. Cytogenetically, all cases had complex karyotypes being especially significant the losses of the chromosomes 4, 13, and 17. As a whole, 11 of 29 (38%) analyzed OS presented alterations in some of the analyzed G1 to S-phase checkpoint genes. These alterations were more frequently present in adults (P = 0.032). All patients with genetic alterations in the G1/S-phase checkpoint died during their clinical follow-up, whereas more than 53% of the remaining cases were alive in this period (P = 0.007). Hence, in the pathogenesis of human OS, deregulation of the G1/S checkpoint genes, especially RB, TP53, and INK4/ARF locus, plays an important role and defines a subgroup of patients with a poor outcome.
Insights
Alterations in G1/S checkpoint genes like RB and TP53 are common in osteosarcoma (OS). These genetic changes in OS patients are linked to a poor prognosis, especially in adults.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma (OS) is characterized by complex karyotypes, suggesting the involvement of multiple oncogenes and tumor suppressor genes.
- The G1 to S-phase checkpoint is crucial for cell cycle regulation and preventing genomic instability.
Purpose of the Study:
- To investigate molecular alterations in G1 to S-phase checkpoint genes in osteosarcoma pathogenesis.
- To determine the clinical significance of these alterations in OS patients.
Main Methods:
- Analysis of RB, TP53, INK4A/ARF locus, CDK4, MDM2, and Cyclin D genes in 29 osteosarcoma samples.
- Detection of homozygous deletion, methylation, co-amplification, and differential gene expression.
- Cytogenetic analysis of complex karyotypes, focusing on chromosome losses.
Main Results:
- Molecular alterations in G1/S checkpoint genes were found in 38% of OS cases.
- RB and TP53 alterations occurred in 21% and 10% of cases, respectively.
- INK4A/ARF locus deletions/methylation and CDK4/MDM2 co-amplification were also observed.
- These genetic alterations were more frequent in adult patients and significantly correlated with a poor prognosis (100% mortality vs. 53% survival).
Conclusions:
- Deregulation of G1/S checkpoint genes, particularly RB, TP53, and INK4A/ARF, plays a significant role in osteosarcoma development.
- Identification of these genetic alterations defines a subgroup of osteosarcoma patients with a poor clinical outcome.
Related Concept Videos
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity
Positive Regulator Molecules

